Wavefront Analysis and Contrast Sensitivity After Cataract Surgery With Akreos Advanced Optics Intraocular Lens Implantation

Sponsor
University of Sao Paulo (Other)
Overall Status
Completed
CT.gov ID
NCT00863759
Collaborator
(none)
25
1
2
8
3.1

Study Details

Study Description

Brief Summary

Purpose: To determine whether implantation of an intraocular lens (IOL) with a modified anterior and posterior aspherical surface (Akreos AO, Bausch & Lomb,Inc) results in reduced ocular aberrations (spherical aberration) and in improved contrast sensitivity after cataract surgery.

Study hypothesis: the implantation of an intraocular lens (IOL) with a modified anterior and posterior aspherical surface (Akreos AO, Bausch & Lomb,Inc) results in reduced ocular aberrations (spherical aberration) and improved contrast sensitivity after cataract surgery.

Setting: Department of ophthalmology, Hospital das Clínicas, University of São Paulo, São Paulo, Brazil.

Overall Study design: This will be an intraindividual randomized double-blinded prospective study. Patients will be randomized to receive an aspheric IOL Akreos AO in one eye (25 eyes; Bausch & Lomb, Inc), and an spheric IOL Akreos Fit (25 eyes; Bausch & Lomb, Inc.) in the fellow eye. Ocular aberrations with a 5.0 mm and 6.0 mm pupil will be measured with a dynamic retinoscopy aberrometer after 1 and 3 months. Uncorrected and best-corrected visual acuity, out-focus performance and contrast sensitivity under mesopic and photopic conditions will be also measured. All patients will be followed for 3 months.

Condition or Disease Intervention/Treatment Phase
  • Procedure: implantation of intraocular lens (IOL)
N/A

Detailed Description

Patients with bilateral visually significant cataract with corneal astigmatism lower than 2.0D (diopters) will be eligible for inclusion in the study. Exclusion criteria will be any ocular diseases, such as corneal opacities or irregularity, dry eye, amblyopia, anisometropia, glaucoma, retinal abnormalities, surgical complications, IOL tilt, IOL decentration greater than 0.4 mm (estimated by retroillumination), or incomplete follow-up.

Patients will be examined before surgery and at 1, 7, 30, 90 days after surgery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
25 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Wavefront Analysis and Contrast Sensitivity After Cataract Surgery With Akreos AO Intraocular Lens Implantation: Clinical Comparative Study
Study Start Date :
Mar 1, 2009
Actual Primary Completion Date :
Nov 1, 2009
Actual Study Completion Date :
Nov 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 1

Patients will receive an aspheric intraocular lenses (IOL) Akreos AO in the right eye and an spheric IOL Akreos Fit in the left eye, during cataract surgery.

Procedure: implantation of intraocular lens (IOL)
implantation of intraocular lens during cataract surgery. Arm 1: implantation of aspheric IOL Akreos AO in right eye and an spheric IOL Akreos Fit in left eye. Arm 2: implantation of aspheric IOL Akreos AO in left eye and an spheric IOL Akreos Fit in right eye.
Other Names:
  • Implantation of aspheric Akreos AO intraocular lenses (IOL)
  • Implantation of spheric Akreos Fit intraocular lenses (IOL)
  • Active Comparator: 2

    Patients will receive an spheric intraocular lens (IOL) Akreos Fit in the right eye and an aspheric IOL Akreos AO in the left eye, during cataract surgery.

    Procedure: implantation of intraocular lens (IOL)
    implantation of intraocular lens during cataract surgery. Arm 1: implantation of aspheric IOL Akreos AO in right eye and an spheric IOL Akreos Fit in left eye. Arm 2: implantation of aspheric IOL Akreos AO in left eye and an spheric IOL Akreos Fit in right eye.
    Other Names:
  • Implantation of aspheric Akreos AO intraocular lenses (IOL)
  • Implantation of spheric Akreos Fit intraocular lenses (IOL)
  • Outcome Measures

    Primary Outcome Measures

    1. Ocular aberrations with a 5.0 mm and 6.0 mm pupil measured with a dynamic retinoscopy aberrometer [At 30 and 90 days postoperatively]

    Secondary Outcome Measures

    1. Days contrast sensitivity under photopic and mesopic conditions [at 90 days postoperatively]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients with bilateral visually significant cataract with corneal astigmatism lower than 2.0D (diopters)
    Exclusion Criteria:
    • Ocular diseases, such as corneal opacities or irregularity, dry eye amblyopia, anisometropia, glaucoma, retinal abnormalities

    • Surgical complications

    • Intraocular lens (IOL) tilt, IOL decentration greater than 0.4 mm (estimated by retroillumination)

    • Incomplete follow-up.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 : Department of ophthalmology, Hospital das Clinicas, University of São Paulo São Paulo Brazil 05403.001

    Sponsors and Collaborators

    • University of Sao Paulo

    Investigators

    • Principal Investigator: Marcony R Santhiago, MD, University of Sao Paulo (ophthalmology department of Hospital das Clinicas)

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00863759
    Other Study ID Numbers:
    • 656/06
    First Posted:
    Mar 18, 2009
    Last Update Posted:
    Jul 2, 2010
    Last Verified:
    Mar 1, 2009

    Study Results

    No Results Posted as of Jul 2, 2010